Multiple companies have offered exome sequencing to consumers. Knome was the first company to offer exome sequencing services to consumers, at a cost of several thousand dollars. Later, 23andMe ran a pilot WES program that was announced in September 2011 and was discontinued in 2012. Consumers could obtain exome data at a cost of $999. The company provided raw data, and did not offer analysis.
In November 2012, DNADTC, a division of Gene by Gene started offering exomes at 80X coverage and introductory price of $695. This price per DNADTC web site is currently $895. In October 2013, BGI announced a promotion for personal whole exome sequencing at 50X coverage for $499. 
In June 2016 Genos was able to achieve an even lower price of $399 with a CLIA-certified 75X consumer exome sequenced from saliva.
A 2018 review of 36 studies found the cost for exome sequencing to range from $555USD to $5,169USD, with a diagnostic yield ranging from 3% to 79% depending on patient groups.